Saccharomyces cerevisiae oesophagitis in a patient with oesophageal carcinoma

  • Dimas Alexandre Kliemann Pulmonary Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
  • Vicente Sperb Antonello Infection Control Department, Hospital Fêmina, Porto Alegre, Brazil
  • Luis Carlos Severo Pulmonary Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
  • Alessandro Comarú Pasqualotto Pulmonary Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Keywords: opportunistic infections, oesophagitis, saccharomyces, yeasts, probiotics, cancer

Abstract

Saccharomyces species are emerging opportunistic fungal pathogens that can cause bloodstream infections in humans. These infections have often been associated with the ingestion of probiotics. Saccharomyces oesophagitis is a rare condition which has been described so far in only two publications. Here we report the case of a patient who was diagnosed with Saccharomyces oesophagitis. The clinical picture was indistinguishable from that of Candida oesophagitis. The Saccharomyces isolate was shown to be susceptible to fluconazole by both CLSI M27-A and disk diffusion methods. In contrast to cases of fungaemia, Saccharomyces oesophagitis does not seem to follow probiotic use. Due to the potential for antifungal resistance among emerging fungal pathogens, proper mycological identification at the species level is essential.

Published
2011-06-30
How to Cite
1.
Kliemann DA, Antonello VS, Severo LC, Pasqualotto AC (2011) Saccharomyces cerevisiae oesophagitis in a patient with oesophageal carcinoma. J Infect Dev Ctries 5:493-495. doi: 10.3855/jidc.1630
Section
Case Reports